Skip to main content
Publication date
2018 03 16
Authors
Ladds, MJGW van Leeuwen, IMM Drummond, CJ Chu, S Healy, AR Popova, G Fernandez, AP Mollick, T Darekar, S Sedimbi, SK Nekulova, M Sachweh, MCC Campbell, J Higgins, M Tuck, C Popa, M Safont, MM Gelebart, P Fandalyuk, Z Thompson, AM Svensson, R Gustavsson, AL Johansson, L Farnegardh, K Yngve, U Saleh, A Haraldsson, M D'Hollander, ACA Franco, M Zhao, Y Hakansson, M Walse, B Larsson, K Peat, EM Pelechano, V Lunec, J Vojtesek, B Carmena, M Earnshaw, WC McCarthy, AR Westwood, NJ Arsenian-Henriksson, M Lane, DP Bhatia, R McCormack, E Lain, S
Author KI Usernames
Arsenian-Henriksson, M|marhen Franco, M|mfranc Gustavsson, AL|gustav Haraldsson, M|mahara Ladds, MJGW|marlad Lain, S|sonlai Laín, S|sonlai Lane, DP|davlan Larsson, K|karila Pelechano, V|vicpel Popova, G|gerpop Sedimbi, SK|saised van Leeuwen, IMM|invanl
Pubmed ID
29549331
Journal
Nature communications
Doctype
Article
KI Connection
Hög
Mesh SV
Cellcykel Cellgifter Cellproliferation Enzymhämmare Indazoler Människa Proteolys Tumörcellinje Tumörer Tumörsuppressorprotein p53
Mesh EN
Antineoplastic Agents Cell Cycle Cell Line, Tumor Cell Proliferation Enzyme Inhibitors Indazoles Neoplasms Oxidoreductases Acting on CH-CH Group Donors Proteolysis Tumor Suppressor Protein p53
First date
2018-04-09T01:35:11.24Z